Evidence map›Paper›PMID 27670347›Full record

ArticleNature communications2016

Twister ribozymes as highly versatile expression platforms for artificial riboswitches.

Michele Felletti, Julia Stifel, Lena A Wurmthaler, Sophie Geiger, Jörg S Hartig

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. gRNAde: Geometric Deep Learning for 3D RNA inverse design.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Riboswitches, from cognition to transformation.Synthetic and systems biotechnology · 2023
    Review
  17. Article
  18. Ribocentre: a database of ribozymes.Nucleic acids research · 2023
    Article
  19. Article
  20. Practical genetic control strategies for industrial bioprocesses.Journal of industrial microbiology & biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michele FellettiDepartment of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
Julia StifelDepartment of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
Lena A WurmthalerDepartment of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
Sophie GeigerDepartment of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
Jörg S HartigDepartment of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
University of Konstanz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utilization of ribozyme-based synthetic switches in biotechnology has many advantages such as an increased robustness due to in cis regulation, small coding space and a high degree of modularity. The report of small endonucleolytic twister ribozymes provides new opportunities for the development of advanced tools for engineering synthetic genetic switches. Here we show that the twister ribozyme is distinguished as an outstandingly flexible expression platform, which in conjugation with three different aptamer domains, enables the construction of many different one- and two-input regulators of gene expression in both bacteria and yeast. Besides important implications in biotechnology and synthetic biology, the observed versatility in artificial genetic control set-ups hints at possible natural roles of this widespread ribozyme class.

Identifiers

PMID27670347
PMCPMC5052635
OpenAlexW2523935508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.